EGFR and non-small cell lung carcinoma: Zhang et al. [51] reported that EREG mRNA expression was reduced through treatment with an EGFR-TKI or an MEK inhibitor in EGFR-mutant NSCLC cell in which EREG attenuation led to the inhibition of cell proliferation and invasion and induced apoptosis.